Sort by
Refine Your Search
-
Listed
-
Employer
- Nature Careers
- ICN2
- Centre for Genomic Regulation
- Universidad de Huelva
- Fundacion para la Investigacion e Innovacion Biosanitaria de Atencion Primaria
- Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)
- Institute of Photonic Sciences
- CITMAga - Galician Center for Mathematical Research and Technology
- UNIOVI
- Universitat Politècnica de Catalunya (UPC)- BarcelonaTECH
- universidad de huelva
- 1 more »
- « less
-
Field
-
Key Laboratory Career Development Outstanding full-time postdoctoral fellows will be given priority consideration for transition to Junior PI or other faculty positions through an expedited evaluation
-
for three consecutive periods (2014-2018 and 2018-2022 and 2023-2026). ICN2 comprises 19 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering different
-
infrastructures, and unique professional career development opportunities. To check out our training and development portfolio, please visit our website in the training section . We offer and promote a diverse and
-
-of-the-art core facilities + generous research funding ✓ Comprehensive relocation support (housing subsidies, family assistance) ✓ Visa sponsorship + career development programs Application Submit CV (format
-
of Design Chen 86-755-88012846 chenly3@mail.sustech.edu.cn School of Semiconductors (National Program for Development of Exceptional Engineers) Ouyang hr-zgxy@sustech.edu.cn Institute for Quantum Science
-
for three consecutive periods (2014-2018 and 2018-2022 and 2023-2026). ICN2 comprises 20 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering different
-
-of-the-art infrastructures, and unique professional career development opportunities. To check out our training and development portfolio, please visit our website in the training section . We offer and
-
scientific disciplines at the IAT. You should get involved in national and international research contexts. Central to this is the planning and implementation of joint projects and the (further) development
-
trial operations in 2026. As the cornerstone of the university’s forthcoming School of Medicine, it will accelerate the development of breakthrough therapies while delivering exceptional clinical services
-
for three consecutive periods (2014-2018 and 2018-2022 and 2023-2026). ICN2 comprises 20 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering different